Signaling Pathways Related to Diabetic Peripheral Neuropathy Treated by Chinese Medicine: A Review / 中国实验方剂学杂志
Chinese Journal of Experimental Traditional Medical Formulae
;
(24): 261-267, 2023.
Article
Dans Chinois
| WPRIM
| ID: wpr-965671
ABSTRACT
Diabetic peripheral neuropathy (DPN) is one of the common complications of diabetes. The disease has a long course with nerve pain and other symptoms, seriously affecting the quality of life of patients. DPN is related to high glucose in vivo, inflammation, oxidative stress, apoptosis, and autophagy, involving phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK), and other signaling pathways. At present, the treatment of DPN mainly focuses on symptomatic treatments such as blood glucose control and neurotrophic therapy, but the effect is not ideal. Therefore, it is particularly important to select a reasonable and effective drug to prevent and treat DPN. In recent years, Chinese medicine has played an important role in the treatment of DPN. Many studies have explored the mechanism of Chinese medicine in the treatment of DPN, and it has been found that some Chinese medicine monomers and compounds can regulate signaling pathways to prevent and treat DPN. This paper reviewed the research results of signaling pathways involved in DPN and the regulation of related pathways by Chinese medicine, aiming to provide references for the clinical treatment of DPN.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Chinese Journal of Experimental Traditional Medical Formulae
Année:
2023
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS